Veterinary Molecular Diagnostics Market
Market Insights on Veterinary Molecular Diagnostics covering sales outlook, demand forecast & up-to-date key trends
Veterinary Molecular Diagnostics Market By Product Type (PCR Kits, RT-PCR Kits, RAPD-PCR Kits, INAAT Kits, Microarray Kits, DNA Sequencing Kits), Species Type (Livestock Animals, Companion Animals), Disease Type (Anaplasma spp, Ehrlichia spp, New Castle Disease, Influenza) & Region - Forecast 2022 - 2028
Veterinary Molecular Diagnostics Market Snapshot (2022-2028)
[275 Pages Report] The global veterinary molecular diagnostics market is estimated to expand from a value of US$ 168.7 Mn in 2021, to a value of US$ 277.2 Mn US$ 277.2 Mn by 2028 end. Owing to the rising prevalence of animal diseases coupled with increasing need for early detection, identification and genotyping of pathogens, sales of veterinary molecular diagnostic products are projected to rise at 7.2% CAGR throughout the forecast period.
Veterinary molecular diagnostics products have become ideal solutions for the detection of animal diseases due to their quick and accurate results capabilities. With growing consumer awareness about maintaining good pet health and rapid expansion of veterinary biologics market, demand for veterinary molecular diagnostics is projected to grow at a significant pace over the forecast period.
RT-PCR technology has proved to be an effective diagnostic technique over DNA sequencing, on account of being early, rapid and sensitive veterinary molecular diagnostics - as it exhibits about 99% specificity. It is particularly gaining wider popularity due to the fact that over 85% of the animals are diagnosed using these RT-PCR based home kits. Thus, rapid growth of veterinary home diagnostics market will continue to provide conducive environment for the expansion of veterinary molecular diagnostics market during the forecast period.
Increasing pet healthcare spending, particularly vet care on livestock and companion animals worldwide pushes market players to come in pet care diagnostic segment. Manufacturers of veterinary molecular diagnostic kits are focusing on developing novel and innovative kits for diagnosing and treating various diseases.
Ease of FDA approval for animal molecular diagnostic kits and reagents coupled with rising awareness of animal diseases among pet owners and development of novel products with high test sensitivity and specificity is promoting the veterinary molecular diagnostics market in North America and European countries. This, in turn, would further bring bundle of opportunities for molecular test kit manufacturers across these region in future.
|
Data Points |
Market Insights |
|
Veterinary Molecular Diagnostics Market Value 2022 |
US$ 182.1 Mn |
|
Veterinary Molecular Diagnostics Market Forecast Value (2028) |
US$ 277.2 Mn |
|
Veterinary Molecular Diagnostics Market Growth Rate 2022-2028 |
7.2% |
|
Top 5 Countries % Share, 2021 |
59.3% |
|
Key Players |
bioMérieux SA, IDEXX Laboratories, Inc, Thermo Fisher Scientific Inc., Qiagen N.V., Neogen Corporation are the key players in veterinary molecular diagnostics market |
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1 - 2021 |
7.39% |
|
H1 – 2022 Projected |
7.25% |
|
H1 – 2022 Outlook |
7.15% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change– H1, 2022 (O) – H1, 2021 |
(-) 24 ↓ |
The market is contingent to the regulations and technical breakthroughs in accordance with impact of macro, economic, and industry factors. The potential to prevent or curtail developing or future epidemics, aid in contact tracing, and support routing of the geographical distribution and onset of infectious diseases in practically real time are just a few of the key breakthroughs in the veterinary molecular diagnostics market.
FMI provides a relative investigation regarding the market growth rates and development prospects in the global veterinary molecular diagnostics market.
According to Future Market Insights’ analysis, the market is expected to decline by 24 Basis Point Share (BPS) in H1- 2022 (O) as compared to H1-2021. The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 BPS units.
Major reasons for this dip in BPS are attributed to the logistical challenges in live material required for phenotyping tests, and extremely high levels of sequence polymorphism, particularly of livestock, which makes categorizing causal resistance mutations, perplexing.
In contrast with the mentioned aspects above, there are some driving points that impact the industry growth, including the applicability of diagnostic point?of?care tests (POCTs) for infectious and zoonotic animal diseases in developing countries, and the early identification and management of infected animals.
2013-2021 Veterinary Molecular Diagnostics Market Demand Outlook Compared to 2022-2028 Forecast
The global sales of veterinary molecular diagnostics are forecast to grow at a CAGR of 7.2% between 2022 and 2032, in comparison to 6.8% CAGR registered from 2013 and 2021.
In 2021, the global market of veterinary molecular diagnostics accounted for approx. 6.8% of the overall veterinary diagnostics market standing at a valuation ofUS$ 2.5 Bn.
Increased consumer spending on veterinary care is creating huge demand within the veterinary molecular diagnostics market. As per the American Pet Products Association (APPA), spending on vet care has soared faster than the GDP over the past two years. With the rise in pet ownership, the overall spending on vet care is booming, thereby providing a strong thrust to the growth of veterinary molecular diagnostics market.
Similarly, according to an annual survey by the American Pet Products Association, Americans spent around US$ 125.1 billion on Animal care in 2020. Rising health issues among dogs and larger animals have created a larger financial burden on their owners. In order to minimize this burden and enhance the health of pets, people are opting for veterinary molecular diagnostic tests,
High spending from people on veterinary services and rise in internet tool for knowledge sharing about animal health have made people realize the importance of regular checkups. The growing demand for veterinary molecular diagnostics over conventional procedures is further expected to fuel the growth of the veterinary molecular diagnostics market.
Moreover, rapid expansion of animal molecular diagnostics kit market and pet medical test market is anticipated to generate lucrative growth prospects for the manufacturers of veterinary molecular diagnostics during the forecast period.
Based on the aforementioned factors, the global, the global veterinary molecular diagnostics market is projected to grow at a CAGR of 7.2% over the forecast period.
Impact on Veterinary Molecular Diagnostics Market?
Country level lockdown of big economies severely impacted the veterinary molecular diagnostics market in a negative way. This negative impact was due to limited production of diagnostic kits, transportation-related delays owing to travel restriction and driver shortages. Geographic location was also considered to be one of the significant factors for the veterinary molecular diagnostics market supply chain.
Visits to diagnostic centers were drastically reduced from third quarter of 2020 until the mid of 2021. At present, the industry is recovering at a steady rate and all the key players of the industry have shifted their focus on the efforts to balance their overall losses due to the worldwide lockdown.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Factors Are Restraining Demand for Veterinary Molecular Diagnostics Market?
The rising pet care costs and demand for medical tests and relative need for expensive diagnostic equipment for veterinary molecular diagnosis is expected to restrain the overall market growth High cost associated with these testing equipment together with limited access to these high costing diagnostic tests has come out to be the biggest hindrance, averting more frequent use of molecular diagnostic techniques. Moreover, the molecular diagnostic technique is cost prohibitive for a large number of pet owners as they do not have pet insurance scheme. Availability & preference for alternative inexpensive diagnostic methods over the expensive RT-PCR test can be seen trending in the market.
Additionally, in various endemic countries, there has been variations in veterinary disease pattern over a period of time owing to the discovery of new virulent. On the other hand, there has also been a very limited knowledge and understanding amongst doctorsabout the epidemiological pattern of these diseases in such countries, thereby creating large gaps. . All these factors are expected to retrain the growth of veterinary molecular diagnostics market during the forecast period.
Veterinary Molecular Diagnostics Market - Country-wise Insights
What Makes the U.S. a Large Market for Veterinary Molecular Diagnostics Market?
“Rising Adoption of Pets Creating sales Prospects Across U.S.”
The U.S. is estimated to account for nearly 88.6% of the North America veterinary molecular diagnostics market demand in 2022. High adoption of pets by U.S population and incraesing investments by the pet parents in maintaining the health of their pets is expected to drive the demand for veterinary molecular diagnostics market in this country.
According to the APPA (American Pet Products Association), in 2017, an estimated 63 million households in the United States owned a dog. Increasing pet adoption rates will, in turn, increase the pool of pets in the veterinary clinics for diagnosis. This is bound to generate gigantic revenues in the U.S. veterinary molecular diagnostics market in future.Furthermore, re-emerging concept of ‘One Health’ has impacted the field of molecular testing, especially for the management of infectious diseases. The concept aims at provision of high-throughput molecular screening for companion animals across the involved countries like U.S.
In addition to this, exponential growth of veterinary molecular diagnostics kit market across the U.S. will further create growth prospects within the veterinary molecular diagnostics market in future.
Why is Germany Considered a Lucrative Market for Veterinary Molecular Diagnostics?
“Rising Initiatives for Eradicating Animals Diseases Driving Market in Germany”
Germany is estimated to account for 34.0% market value share in European veterinary molecular diagnostics market in 2022. Factors such as increased government funding and support for international animal disease eradication programs is boosting the demand for veterinary molecular diagnostics market in Germany.
International agencies and organizations such as the World Organization for Animal Health (OIE), Centre for Disease Prevention and Control (CDC) and Food and Agriculture Organization have made major contributions to reduce animal diseases and eradicate them by controlling and monitoring programs for animal diseases. Introduction of such financial grants to support research and development activities for molecular screening of animal disease is further expected to boost the growth of the global veterinary molecular diagnostics market in terms of revenue.
“EU funded the PAN-SPSO project to encourage African countries to develop animal services. The Stop Transboundary Animal Diseases and Zoonoses were funded by the Australian Agency of International Development for Disease Management and Vaccination Programs in Southeast Asia with the OIE/Japan Trust Fund Project and FAO/Republic of Korea project on FMD control in Asia.”
Additionally, rapid expansion of pet medical test market due to increasing adoption of low-cost medical tests for early detection of diseases is anticipated to further accelerate the growth of veterinary molecular diagnostics market across Germany in future.
What are the Factors Fueling the Demand for Veterinary Molecular Diagnostics in France?
Growing popularity of Molecular Diagnostic Techniques for Quick and Accurate Detection of Animal Diseases Boost Market Growth”
France is estimated to account for nearly 15.8% of the global veterinary molecular diagnostics market share in 2022 and is projected to grow at a CAGR of around 7.9% during the forecast period.
France has shifted the healthcare standards for veterinary care in recent years. Most of the private veterinarians in earlier times did not have an X-ray machine. Pets did not get effective diagnosis and treatment facilities. But as public attitudes toward pets started changing, the veterinary diagnosis with standards care also began.
People in France are now adopting the molecular diagnostic techniques which is the latest innovative vet care diagnostic method. Growing popularity of veterinary molecular diagnostics can be mainly attributed to the advancements in veterinary biologics market.The veterinary molecular diagnostics market in this region is thus, expected to grow rapidly in the near future.
How will the Veterinary Molecular Diagnostics Market Grow Across India?
“Expansion of Veterinary Healthcare Services Spurring Market Growth in India”
Demand for veterinary molecular diagnostics in India is expected to grow at a CAGR of around 5.6% over the forecast period from 2022 to 2028.
During the last few years, adoption of pets like dogs and cats across India has been on the rise and the trend is likely to continue in the future. This rise in pet adoption number is genertaing demand forveterinary healthcare services like molecular diagnostic tests and treatments
Additionally, increasing prevalence of animal diseases along with flourishing pet medical test market across the country will further generate demand for veterinary molecular diagnostics during the forecast period.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Veterinary Molecular Diagnostics Market - Category-wise Insights
Which Product Type Exhibits Strong Demand?
“Attractive Features of PCR Kits Making them High Sought After Diagnostic Products”
PCR Kits accounted for the highest value share of nearly 50.7% in 2021 due to its availability at less cost and high specificity as compared to microarray and INAAT kits.
Additionally, onset of new technologies such as rapid RT-PCR being most reliable technique with 99% specificity and high efficiency is expected to create more demand for PCR kits by end users. PCR kits are highly used in home testing, veterinary clinics, and diagnostic centers. Rapid expansion of veterinary home diagnostics market will therefore continue to Push the sales of PCR kits in the future.
By Species Type, Which Segment Leads the Global Veterinary Molecular Diagnostics Market?
“Increasing Prevalence of Diseases in Livestock Animals Fueling Adoption of Veterinary Molecular Diagnostic Products”
Based on species type, livestock animals segment dominates the global veterinary molecular diagnostics market, accounting for a revenue share of around 71.0% in 2022. This is mainly due to rising cases of uncured influenza and growing adoption of veterinary molecular diagnostic products like PCR kits and DNA sequencing kits for early detection of diseases in livestock animals.
Most of the livestock diastases can be easily detected and identified by using veterinary molecular diagnostics. Moreover, awareness of zoonotic diseases in livestock animals is creating major revenue opportunities for the market players in this industry.
Which Disease Type Accounts for the Majority of Revenue Share in the Global Veterinary Molecular Diagnostics Market?
Rise in Influenza and New Castle Disease Cases Generating Maximum Sales Prospects for veterinary Molecular Diagnostics”
By disease Type, influenza and new castle disease are the two leading segments together accounting for over 58% of the global market share by value in 2022.
Influenza and new castle diseases are the two most commonly found diseases in animals. They are not cured in many animals with conventional treatment. There is a high need for molecular therapy, required for treatment and diagnosis in animals.
These diseases affect several animals, such as horses, cats, dogs, birds and swine, and can have a devastating impact on their health. The laboratory testing thus becomes important to confirm the diagnosis of these diseases. This is usually done with the help of veterinary molecular diagnostics.
Which End User Segment Leads the Veterinary Molecular Diagnostics Market?
“Majority of the Veterinary Molecular Diagnostic Sales to Remain Concentrated in Veterinary Hospitals Segment”
By end user, veterinary hospitals segment leads the veterinary molecular diagnostics market with a massive revenue share of around 49.7% in 2022. Most of the walk-in patients for vet care, prefer to go to veterinary hospital for vet care, as the treatment and diagnosis is inexpensive and easily available in veterinary hospitals.
Rising preference for treating animals at veterinary hospitals is anticipated to trigger segment growth during the forecast period.
Veterinary Molecular Diagnostics Market Competitive Landscape
The veterinary molecular diagnostics market is an extremely consolidated market, with major competitors such as bioMérieux SA, IDEXX Laboratories, Inc., Neogen Europe, Ltd., Veterinary Molecular Diagnostics, Inc., Thermo Fisher Scientific, Inc., ID-Vet, and Qiagen N.V operating in every region of the globe. To attract more customers, these players are focusing on adopting growth strategies such as mergers, acquisition and novel product launches. Furthermore, manufacturers are concentrating their efforts on obtaining regional regulatory approvals for their products. In the coming years, these initiatives are projected to fuel the expansion of the veterinary molecular diagnostics market.
-
In September 2021, QIAGEN N.V. won a U.S. government contract to increase the production capacity for consumables used in integrated PCR testing systems.
-
In Sept 2021, IDEXX Foundation took initiatives with registered charitable organizations located in Maine, home to IDEXX’s World Campus. These local organizations aligned with the IDEXX Foundation’s mission to help create positive, lasting impacts for animals, people, and the environment through inclusive, outcomes-focused initiatives in communities around the world.
Scope of the Report
Future Market Insights latest analysis examines how advancement in molecular diagnostic technologies is revolutionizing the veterinary molecular diagnostics market. It provides comprehensive details on how market players are innovating to meet the end user demands.
The report is intended to enlighten customers with significant details about market drivers, opportunities, restraints, and emerging trends. With its compelling insights, the report gives a comprehensive analysis of the overall market dynamics.
A certain number of chapters have been dedicated to analyzing geographic assessment including comprehensive details on drivers and opportunities prevalent exclusively in key regional pockets. While North America and Europe remains at the epicenter of veterinary molecular diagnostics market growth, thanks to growing popularity of molecular diagnostic techniques, Asia is likely to catch up soon. Factors making conducive environment for growth across Asia have been studied in detail.
The study also highlights why veterinary biologics market is experiencing substantial growth and how it affects the veterinary molecular diagnostics demand. Besides this, impact of government initiatives and growing awareness among pet owners on veterinary molecular diagnostics market has been studied in detail.
The Veterinary Molecular Diagnostics Market Analysis Includes:
- A 6-year realistic sales forecast of veterinary molecular diagnostics across 3 end use verticals
- Compelling insights into various diagnostic products, their effectiveness and popularity among end users
- Market dynamics including drivers, restraints, and emerging opportunities
- Growth tactics employed by key market players to increase sales
- Recent developments and advancements in molecular diagnostic's techniques
|
Attribute |
Details |
|
Forecast Period |
2022-2028 |
|
Historic Data Available for |
2013-2021 |
|
Market Analysis |
USD Million for Value |
|
Report Coverage |
Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
|
Key Segments Covered |
|
|
Key regions covered |
|
|
End User |
|
|
Key companies profiled |
bioMérieux SA, IDEXX Laboratories, Inc., Neogen Europe, Ltd., Veterinary Molecular Diagnostics, Inc., Thermo Fisher Scientific, Inc., ID-Vet, Qiagen N.V. |
|
Customization & pricing |
Available upon request |
Veterinary Molecular Diagnostics Market by Category
By Product:
- PCR Kits
- RT-PCR Kits
- RAPD-PCR Kits
- INAAT Kits
- Microarray Kits
- DNA Sequencing Kits
By Species type:
- Livestock Animals
- Equine
- Porcine
- Poultry
- Cattle
- Aquatic
- Ovine
- Companion Animals
- Canine
- Feline
- Avian
By Disease Type:
- Anaplasma spp.
- Ehrlichia spp.
- New Castle Disease
- Influenza
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Others
By End User:
- Veterinary Hospitals
- Clinical Laboratories
- Veterinary Research Institutes
By Region:
- North America
- Latin America
- Europe
- APEC
- MEA
- China
Frequently Asked Questions
The global Veterinary molecular diagnostics market is worth US$ 168.7 Mn in 2021 and is set to expand with CAGR of 7.2% over forecast period.
The market is expected to reach US$ 277.2 Mn by the end of 2028.
The sales of veterinary molecular diagnostics market have grown at a CAGR of nearly 6.8% between 2013 and 2021.
RT-PCR Kits have huge growth opportunities for veterinary molecular diagnostics market and is expected to grow at a CAGR of nearly 7.9% between 2022 and 2028.
US, Germany and Spain are the top 3 countries that are driving the demand for veterinary molecular diagnostics market.
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Veterinary Molecular Diagnostics Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. List of Growth Hacking Manufacturers
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity Analysis
4.2.4. Trends
4.3. Regulatory Scenario
5. Key Inclusions
5.1. Key Competition Mapping
6. North America Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028
6.1. Introduction
6.2. Historical Market Size (US$ Mn) & Analysis by Country, 2013-2021
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) & Forecast By Country, 2022–2028
6.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2013-2021
6.4.1. PCR KITS
6.4.1.1. RAPD-PCR Kits
6.4.1.2. Real Time PCR Kits
6.4.2. INAAT KITS
6.4.3. Microarray Kits
6.4.4. DNA Sequencing Kits
6.5. Market Size (US$ Mn) and Forecast By Product, 2022–2028
6.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2013-2021
6.6.1. Anaplasma spp.
6.6.2. Ehrlichia spp.
6.6.3. New Castle Disease
6.6.4. Influenza
6.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
6.6.6. Others
6.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
6.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2013-2021
6.8.1. Companion Animals
6.8.1.1. Canine
6.8.1.2. Avian
6.8.1.3. Feline
6.8.2. Livestock Animals
6.8.2.1. Aquatic
6.8.2.2. Bovine
6.8.2.3. Porcine
6.8.2.4. Ovine/Caprine
6.8.2.5. Poultry
6.8.2.6. Equine
6.9. Market Size (US$ Mn) Forecast By Species Type, 2022–2028
6.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2013-2021
6.10.1. Veterinary Hospitals
6.10.2. Clinical Laboratories
6.10.3. Veterinary Research Institutes
6.11. Market Size (US$ Mn) and Forecast By End User, 2022–2028
6.12. Drivers and Restraints: Impact Analysis
6.13. Market Attractiveness Analysis
6.13.1. By Country
6.13.2. By Product
6.13.3. By Disease Type
6.13.4. By Species Type
6.13.5. By End User
6.14. Key Market Participants – Intensity Mapping
7. Latin America Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trends and Analysis by Country, 2013-2021
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) & Forecast By Country, 2022–2028
7.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2013-2021
7.4.1. PCR KITS
7.4.1.1. RAPD-PCR Kits
7.4.1.2. Real Time PCR Kits
7.4.2. INAAT KITS
7.4.3. Microarray Kits
7.4.4. DNA Sequencing Kits
7.5. Market Size (US$ Mn) and Forecast By Product, 2022–2028
7.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2013-2021
7.6.1. Anaplasma spp.
7.6.2. Ehrlichia spp.
7.6.3. New Castle Disease
7.6.4. Influenza
7.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
7.6.6. Others
7.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
7.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2013-2021
7.8.1. Companion Animals
7.8.1.1. Canine
7.8.1.2. Avian
7.8.1.3. Feline
7.8.2. Livestock Animals
7.8.2.1. Aquatic
7.8.2.2. Bovine
7.8.2.3. Porcine
7.8.2.4. Ovine/Caprine
7.8.2.5. Poultry
7.8.2.6. Equine
7.9. Market Size (US$ Mn) Forecast By Species Type, 2022–2028
7.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2013-2021
7.10.1. Veterinary Hospitals
7.10.2. Clinical Laboratories
7.10.3. Veterinary Research Institutes
7.11. Market Size (US$ Mn) and Forecast By End User, 2022–2028
7.12. Drivers and Restraints: Impact Analysis
7.13. Market Attractiveness Analysis
7.13.1. By Country
7.13.2. By Product
7.13.3. By Disease Type
7.13.4. By Species Type
7.13.5. By End User
7.14. Key Market Participants – Intensity Mapping
8. Europe Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) and Trend Analysis by Country, 2013-2021
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Market Size (US$ Mn) & Forecast By Country, 2022–2028
8.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2013-2021
8.4.1. PCR KITS
8.4.1.1. RAPD-PCR Kits
8.4.1.2. Real Time PCR Kits
8.4.2. INAAT KITS
8.4.3. Microarray Kits
8.4.4. DNA Sequencing Kits
8.5. Market Size (US$ Mn) and Forecast By Product, 2022–2028
8.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2013-2021
8.6.1. Anaplasma spp.
8.6.2. Ehrlichia spp.
8.6.3. New Castle Disease
8.6.4. Influenza
8.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
8.6.6. Others
8.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
8.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2013-2021
8.8.1. Companion Animals
8.8.1.1. Canine
8.8.1.2. Avian
8.8.1.3. Feline
8.8.2. Livestock Animals
8.8.2.1. Aquatic
8.8.2.2. Bovine
8.8.2.3. Porcine
8.8.2.4. Ovine/Caprine
8.8.2.5. Poultry
8.8.2.6. Equine
8.9. Market Size (US$ Mn) Forecast By Species Type, 2022–2028
8.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2013-2021
8.10.1. Veterinary Hospitals
8.10.2. Clinical Laboratories
8.10.3. Veterinary Research Institutes
8.11. Market Size (US$ Mn) and Forecast By End User, 2022–2028
8.12. Drivers and Restraints: Impact Analysis
8.13. Market Attractiveness Analysis
8.13.1. By Country
8.13.2. By Product
8.13.3. By Disease Type
8.13.4. By Species Type
8.13.5. By End User
8.14. Key Market Participants – Intensity Mapping
9. Asia Pacific Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2013-2021
9.2.1. India
9.2.2. Australia and New Zealand
9.2.3. Rest of Asia Pacific
9.3. Market Size (US$ Mn) & Forecast By Country, 2022–2028
9.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2013-2021
9.4.1. PCR KITS
9.4.1.1. RAPD-PCR Kits
9.4.1.2. Real Time PCR Kits
9.4.2. INAAT KITS
9.4.3. Microarray Kits
9.4.4. DNA Sequencing Kits
9.5. Market Size (US$ Mn) and Forecast By Product, 2022–2028
9.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2013-2021
9.6.1. Anaplasma spp.
9.6.2. Ehrlichia spp.
9.6.3. New Castle Disease
9.6.4. Influenza
9.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
9.6.6. Others
9.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
9.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2013-2021
9.8.1. Companion Animals
9.8.1.1. Canine
9.8.1.2. Avian
9.8.1.3. Feline
9.8.2. Livestock Animals
9.8.2.1. Aquatic
9.8.2.2. Bovine
9.8.2.3. Porcine
9.8.2.4. Ovine/Caprine
9.8.2.5. Poultry
9.8.2.6. Equine
9.9. Market Size (US$ Mn) Forecast By Species Type, 2022–2028
9.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2013-2021
9.10.1. Veterinary Hospitals
9.10.2. Clinical Laboratories
9.10.3. Veterinary Research Institutes
9.11. Market Size (US$ Mn) and Forecast By End User, 2022–2028
9.12. Drivers and Restraints: Impact Analysis
9.13. Market Attractiveness Analysis
9.13.1. By Country
9.13.2. By Product
9.13.3. By Disease Type
9.13.4. By Species Type
9.13.5. By End User
9.14. Key Market Participants – Intensity Mapping
10. China Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2013-2021
10.2.1. PCR KITS
10.2.1.1. RAPD-PCR Kits
10.2.1.2. Real Time PCR Kits
10.2.2. INAAT KITS
10.2.3. Microarray Kits
10.2.4. DNA Sequencing Kits
10.3. Market Size (US$ Mn) and Forecast By Product, 2022–2028
10.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2013-2021
10.4.1. Anaplasma spp.
10.4.2. Ehrlichia spp.
10.4.3. New Castle Disease
10.4.4. Influenza
10.4.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
10.4.6. Others
10.5. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
10.6. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2013-2021
10.6.1. Companion Animals
10.6.1.1. Canine
10.6.1.2. Avian
10.6.1.3. Feline
10.6.2. Livestock Animals
10.6.2.1. Aquatic
10.6.2.2. Bovine
10.6.2.3. Porcine
10.6.2.4. Ovine/Caprine
10.6.2.5. Poultry
10.6.2.6. Equine
10.7. Market Size (US$ Mn) Forecast By Species Type, 2022–2028
10.8. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2013-2021
10.8.1. Veterinary Hospitals
10.8.2. Clinical Laboratories
10.8.3. Veterinary Research Institutes
10.9. Market Size (US$ Mn) and Forecast By End User, 2022–2028
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Product
10.11.2. By Disease Type
10.11.3. By Species Type
10.11.4. By End User
10.12. Key Market Participants – Intensity Mapping
11. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Trend Analysis by Country, 2013-2021
11.2.1. GCC Countries
11.2.2. South Africa
11.2.3. Rest of MEA
11.3. Market Size (US$ Mn) & Forecast By Country, 2022–2028
11.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2013-2021
11.4.1. PCR KITS
11.4.1.1. RAPD-PCR Kits
11.4.1.2. Real Time PCR Kits
11.4.2. INAAT KITS
11.4.3. Microarray Kits
11.4.4. DNA Sequencing Kits
11.5. Market Size (US$ Mn) and Forecast By Product, 2022–2028
11.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2013-2021
11.6.1. Anaplasma spp.
11.6.2. Ehrlichia spp.
11.6.3. New Castle Disease
11.6.4. Influenza
11.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
11.6.6. Others
11.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
11.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2013-2021
11.8.1. Companion Animals
11.8.1.1. Canine
11.8.1.2. Avian
11.8.1.3. Feline
11.8.2. Livestock Animals
11.8.2.1. Aquatic
11.8.2.2. Bovine
11.8.2.3. Porcine
11.8.2.4. Ovine/Caprine
11.8.2.5. Poultry
11.8.2.6. Equine
11.9. Market Size (US$ Mn) Forecast By Species Type, 2022–2028
11.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2013-2021
11.10.1. Veterinary Hospitals
11.10.2. Clinical Laboratories
11.10.3. Veterinary Research Institutes
11.11. Market Size (US$ Mn) and Forecast By End User, 2022–2028
11.12. Drivers and Restraints: Impact Analysis
11.13. Market Attractiveness Analysis
11.13.1. By Country
11.13.2. By Product
11.13.3. By Disease Type
11.13.4. By Species Type
11.13.5. By End User
11.14. Key Market Participants – Intensity Mapping
12. Forecast Factors: Relevance and Impact
13. Forecast Assumptions
14. Competition Analysis
14.1. Competition Dashboard
14.2. Company Deep Dive
14.2.1. BioMerieux SA
14.2.1.1. Overview
14.2.1.2. Product and Application Portfolio
14.2.1.3. Production Footprint
14.2.1.4. Sales Footprint
14.2.1.5. Channel Footprint
14.2.1.6. Strategy
14.2.1.6.1.1. Marketing Strategy
14.2.1.6.1.2. Product Strategy
14.2.1.6.1.3. Channel Strategy
14.2.2. IDEXX Laboratories, Inc.
14.2.2.1. Overview
14.2.2.2. Product and Application Portfolio
14.2.2.3. Production Footprint
14.2.2.4. Sales Footprint
14.2.2.5. Channel Footprint
14.2.2.6. Strategy
14.2.2.6.1. Marketing Strategy
14.2.2.6.2. Product Strategy
14.2.2.6.3. Channel Strategy
14.2.3. Thermo Fisher Scientific Inc.
14.2.3.1. Overview
14.2.3.2. Product and Application Portfolio
14.2.3.3. Production Footprint
14.2.3.4. Sales Footprint
14.2.3.5. Channel Footprint
14.2.3.6. Strategy
14.2.3.6.1. Marketing Strategy
14.2.3.6.2. Product Strategy
14.2.3.6.3. Channel Strategy
14.2.4. Qiagen N.V.
14.2.4.1. Overview
14.2.4.2. Product and Application Portfolio
14.2.4.3. Production Footprint
14.2.4.4. Sales Footprint
14.2.4.5. Channel Footprint
14.2.4.6. Strategy
14.2.4.6.1. Marketing Strategy
14.2.4.6.2. Product Strategy
14.2.4.6.3. Channel Strategy
14.2.5. Neogene Corporation
14.2.5.1. Overview
14.2.5.2. Product and Application Portfolio
14.2.5.3. Production Footprint
14.2.5.4. Sales Footprint
14.2.5.5. Channel Footprint
14.2.5.6. Strategy
14.2.5.6.1. Marketing Strategy
14.2.5.6.2. Product Strategy
14.2.5.6.3. Channel Strategy
14.2.6. ID.Vet
14.2.6.1. Overview
14.2.6.2. Product and Application Portfolio
14.2.6.3. Production Footprint
14.2.6.4. Sales Footprint
14.2.6.5. Channel Footprint
14.2.6.6. Strategy
14.2.6.6.1. Marketing Strategy
14.2.6.6.2. Product Strategy
14.2.6.6.3. Channel Strategy
14.2.7. INDICAL BIOSCIENCE GmbH
14.2.7.1. Overview
14.2.7.2. Product and Application Portfolio
14.2.7.3. Production Footprint
14.2.7.4. Sales Footprint
14.2.7.5. Channel Footprint
14.2.7.6. Strategy
14.2.7.6.1. Marketing Strategy
14.2.7.6.2. Product Strategy
14.2.7.6.3. Channel Strategy
14.2.8. Veterinary Molecular Diagnostics, Inc.
14.2.8.1. Overview
14.2.8.2. Product and Application Portfolio
14.2.8.3. Production Footprint
14.2.8.4. Sales Footprint
14.2.8.5. Channel Footprint
14.2.8.6. Strategy
14.2.8.6.1. Marketing Strategy
14.2.8.6.2. Product Strategy
14.2.8.6.3. Channel Strategy
15. Global Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028, By Region
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2013-2021
15.3. Market Size (US$ Mn) Forecast By Region, 2022–2028
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. Asia Pacific Excluding China
15.3.5. Middle East & Africa
15.3.6. China
15.4. Market Attractiveness Analysis by Region
16. Global Veterinary Molecular Diagnostics Analysis 2013-2021 and Forecast 2022–2028, By Product
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2013-2021
16.2.1. PCR KITS
16.2.1.1. RAPD-PCR Kits
16.2.1.2. Real Time PCR Kits
16.2.2. INAAT KITS
16.2.3. Microarray Kits
16.2.4. DNA Sequencing Kits
16.3. Market Size (US$ Mn) and Forecast By Product, 2022–2028
16.4. Market Attractiveness Analysis by Product
17. Global Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028, By Disease Type
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2013-2021
17.2.1. Anaplasma spp.
17.2.2. Ehrlichia spp.
17.2.3. New Castle Disease
17.2.4. Influenza
17.2.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
17.2.6. Others
17.3. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
17.4. Market Attractiveness Analysis by Disease Type
18. Global Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028, By Species Type
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2013-2021
18.2.1. Companion Animals
18.2.1.1. Canine
18.2.1.2. Avian
18.2.1.3. Feline
18.2.2. Livestock Animals
18.2.2.1. Aquatic
18.2.2.2. Bovine
18.2.2.3. Porcine
18.2.2.4. Ovine/Caprine
18.2.2.5. Poultry
18.2.2.6. Equine
18.3. Market Size (US$ Mn) Forecast By Species Type, 2022–2028
18.4. Market Attractiveness Analysis by Species Type
19. Global Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028, By End User
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2013-2021
19.2.1. Veterinary Hospitals
19.2.2. Clinical Laboratories
19.2.3. Veterinary Research Institutes
19.3. Market Size (US$ Mn) and Forecast By End User, 2022–2028
19.4. Market Attractiveness Analysis by End User
20. Global Veterinary Molecular Diagnostics Market Analysis 2013-2021 and Forecast 2022–2028
20.1. Market Value Share Analysis by All Segment
20.2. Y-o-Y Growth Analysis by All Segment
20.3. Absolute $ Opportunity
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Key Company and Product Mapping
Table 02: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 03: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product
Table 04: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Species
Table 05: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 06: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 07: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 08: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product
Table 09: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Species
Table 10: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 11: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 12: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 13: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product
Table 14: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Species
Table 15: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 16: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 17: APEC Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 18: APEC Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product
Table 19: APEC Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Species
Table 20: APEC Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 21: APEC Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 22: China Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product
Table 23: China Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Species
Table 24: China Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 25: China Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 26: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 27: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product
Table 28: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Species
Table 29: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 30: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 31: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region
Table 32: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 33: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Species
Table 34: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Disease Type
Table 35: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Value Share 2022E, By Product Type
Figure 02: Global Veterinary Molecular Diagnostics Market Revenue Opportunity Analysis, By Region 2022-2028
Figure 03: Global Veterinary Diagnostics Market Value Share 2021A and 2022E, By Species Type
Figure 04: Global Veterinary Molecular Diagnostics Market, 2021A
Figure 05: Estimated Breakdown of Vet Diagnostics Industry Expenditure (US$ Bn), 2021
Figure 06: Total U.S. Pet Industry Expenditures (US$ Bn), 2021
Figure 07: U.S. Consumer Spending (US$ Bn) on Veterinary Care
Figure 08: Global Vet PCR Diagnostic Kit Average Price, 2017 - 2021
Figure 09: North America Veterinary Molecular Diagnostics Market Value Share, By Product Type (2021A)
Figure 10: North America Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2021A)
Figure 11: North America Veterinary Molecular Diagnostics Market Value Share (2021A), By Species & End User
Figure 12: North America Veterinary Molecular Diagnostics Market Value Share (2021A), By Country
Figure 13: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 14: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 15: U.S. Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 16: U.S. Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 17: Canada Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 18: Canada Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 19: North America PCR Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 20: North America PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 21: North America INAAT Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 22: North America INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 23: North America Microarray Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 24: North America Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 25: North America DNA Sequencing Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 26: North America DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 27: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Livestock Animals, and 2013-2021
Figure 28: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2028
Figure 29: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Companion animals, 2013-2021
Figure 30: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2028
Figure 31: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
Figure 32: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
Figure 33: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
Figure 34: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
Figure 35: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
Figure 36: Latin America Veterinary Molecular Diagnostics Market Value Share, By Product Type (2021A)
Figure 37: Latin America Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2021A)
Figure 38: Latin America Veterinary Molecular Diagnostics Market Value Share (2021A), By Species & End User
Figure 39: Latin America Veterinary Molecular Diagnostics Market Value Share (2021A), By Country
Figure 40: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 41: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 42: Brazil Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 43: Brazil Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 44: Mexico Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 45: Mexico Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 46: Rest of Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 47: Rest of Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 48: Latin America PCR Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 49: Latin America PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 50: Latin America INAAT Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 51: Latin America INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 52: Latin America Microarray Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 53: Latin America Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 54: Latin America DNA Sequencing Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 55: Latin America DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 56: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Livestock Animals, and 2013-2021
Figure 57: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2028
Figure 58: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Companion animals, 2013-2021
Figure 59: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2028
Figure 60: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
Figure 61: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
Figure 62: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
Figure 63: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
Figure 64: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
Figure 65: Europe Veterinary Molecular Diagnostics Market Value Share, By Product Type (2021A)
Figure 66: Europe Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2021A)
Figure 67: Europe Veterinary Molecular Diagnostics Market Value Share (2021A), By Species & End User
Figure 68: Europe Veterinary Molecular Diagnostics Market Value Share (2021A), By Country
Figure 69: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 70: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 71: Germany Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 72: Germany Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 73: UK Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 74: UK Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 75: France Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 76: France Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 77: Italy Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 78: Italy Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 79: Spain Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 80: Spain Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 81: Russia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 82: Russia Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 83: Rest of Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 84: Rest of Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 85: Europe PCR Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 86: Europe PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 87: Europe INAAT Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 88: Europe INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 89: Europe Microarray Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 90: Europe Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 91: Europe DNA Sequencing Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 92: Europe DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 93: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Livestock Animals, and 2013-2021
Figure 94: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2028
Figure 95: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Companion animals, 2013-2021
Figure 96: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2028
Figure 97: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
Figure 98: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
Figure 99: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
Figure 100: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
Figure 101: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
Figure 102: APEC Veterinary Molecular Diagnostics Market Value Share, By Product Type (2021A)
Figure 103: APEC Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2021A)
Figure 104: APEC Veterinary Molecular Diagnostics Market Value Share (2021A), By Species & End User
Figure 105: APEC Veterinary Molecular Diagnostics Market Value Share (2021A), By Country
Figure 106: APEC Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 107: APEC Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 108: India Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 109: India Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 110: Australia & New Zealand Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 111: Australia & New Zealand Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 112: Rest of APEC Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 113: Rest of APEC Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 114: APEC PCR Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 115: APEC PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 116: APEC INAAT Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 117: APEC INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 118: APEC Microarray Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 119: APEC Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 120: APEC DNA Sequencing Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 121: APEC DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 122: APEC Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Livestock Animals, and 2013-2021
Figure 123: APEC Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2028
Figure 124: APEC Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Companion animals, 2013-2021
Figure 125: APEC Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2028
Figure 126: APEC Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
Figure 127: APEC Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
Figure 128: APEC Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
Figure 129: APEC Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
Figure 130: APEC Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
Figure 131: China Veterinary Molecular Diagnostics Market Value Share, By Product Type (2021A)
Figure 132: China Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2021A)
Figure 133: China Veterinary Molecular Diagnostics Market Value Share (2021A), By Species & End User
Figure 134: China Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 135: China Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 136: China PCR Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 137: China PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 138: China INAAT Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 139: China INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 140: China Microarray Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 141: China Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 142: China DNA Sequencing Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 143: China DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 144: China Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Livestock Animals, and 2013-2021
Figure 145: China Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2028
Figure 146: China Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Companion animals, 2013-2021
Figure 147: China Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2028
Figure 148: China Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
Figure 149: China Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
Figure 150: China Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
Figure 151: China Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
Figure 152: MEA Veterinary Molecular Diagnostics Market Value Share, By Product Type (2021A)
Figure 153: MEA Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2021A)
Figure 154: MEA Veterinary Molecular Diagnostics Market Value Share (2021A), By Species & End User
Figure 155: MEA Veterinary Molecular Diagnostics Market Value Share (2021A), By Country
Figure 156: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 157: MEA Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 158: GCC Countries Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 159: GCC Countries Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 160: South Africa Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2013-2021
Figure 161: South Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 162: Rest of MEA Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 163: Rest of MEA Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 164: MEA PCR Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 165: MEA PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 166: MEA INAAT Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 167: MEA INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 168: MEA Microarray Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 169: MEA Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 170: MEA DNA Sequencing Kits Market size (US$ Mn) Analysis, 2013-2021
Figure 171: MEA DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2028
Figure 172: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Livestock Animals, and 2013-2021
Figure 173: MEA Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2028
Figure 174: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, By Companion animals, 2013-2021
Figure 175: MEA Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2028
Figure 176: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
Figure 177: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
Figure 178: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
Figure 179: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
Figure 180: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
Figure 181: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Region, 2022 & 2028
Figure 182: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Region, 2022-2028
Figure 183: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis by Region, 2022-2028
Figure 184: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Product Type, 2022 & 2028
Figure 185: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Product Type, 2022-2028
Figure 186: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis by Product Type, 2022-2028
Figure 187: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Species, 2022 & 2028
Figure 188: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Species, 2022-2028
Figure 189: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis by Species, 2022-2028
Figure 190: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Disease Type, 2022 & 2028
Figure 191: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Disease Type, 2022-2028
Figure 192: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis by Disease Type, 2022-2028
Figure 193: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By End User, 2022 & 2028
Figure 194: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By End User, 2022-2028
Figure 195: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis by End User, 2022-2028
Figure 196: Global Veterinary Molecular Diagnostics Market Value Analysis and Forecast, 2021–2028 (US$ Mn)
Figure 197: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), 2013-2021
Figure 198: Global Veterinary Molecular Diagnostics Market Absolute $ Opportunity (US$ Mn), 2021–2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
